Janus Henderson Global Life Sciences Fund Class N (JFNNX)

Fund Assets	4.66B
Expense Ratio	0.68%
Min. Investment	$1,000,000
Turnover	n/a
Dividend (ttm)	4.07
Dividend Yield	6.15%
Dividend Growth	35.44%
Payout Frequency	Annual
Ex-Dividend Date	Dec 6, 2024

Previous Close	66.12
YTD Return	-2.38%
1-Year Return	-7.59%
5-Year Return	41.37%
52-Week Low	61.60
52-Week High	82.51
Beta (5Y)	0.62
Holdings	116
Inception Date	Jan 26, 2018

About JFNNX

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: JFNNX
• Share Class: Class N
• Index: MSCI World/Health Care NR

Performance

JFNNX had a total return of -7.59% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.02%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JFNIX	Class I	0.77%
JNGLX	Class D	0.80%
JAGLX	Class T	0.92%
JFNAX	Class A	0.98%

Top 10 Holdings

41.64% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	9.39%
UnitedHealth Group Incorporated	UNH	6.87%
AstraZeneca PLC	AZNCF	4.01%
Johnson & Johnson	JNJ	3.59%
Boston Scientific Corporation	BSX	3.13%
Abbott Laboratories	ABT	3.09%
Sanofi	SNYNF	3.05%
Amgen Inc.	AMGN	2.89%
AbbVie Inc.	ABBV	2.82%
Vertex Pharmaceuticals Incorporated	VRTX	2.81%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 6, 2024	$4.06789	Dec 6, 2024
Dec 7, 2023	$3.00343	Dec 7, 2023
Dec 20, 2022	$0.27276	Dec 20, 2022
Dec 20, 2021	$6.91402	Dec 20, 2021
Dec 17, 2020	$5.65748	Dec 17, 2020
Dec 17, 2019	$3.90699	Dec 17, 2019